• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对接受抑制性抗逆转录病毒治疗的供体的CD4 + T细胞进行体外激活,可导致一部分受感染细胞持续产生具有传染性的HIV-1。

Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells.

作者信息

Bui John K, Halvas Elias K, Fyne Elizabeth, Sobolewski Michele D, Koontz Dianna, Shao Wei, Luke Brian, Hong Feiyu F, Kearney Mary F, Mellors John W

机构信息

Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.

Howard Hughes Medical Research Fellows Program, Howard Hughes Medical Institute, Bethesda, Maryland, United States of America.

出版信息

PLoS Pathog. 2017 Feb 22;13(2):e1006230. doi: 10.1371/journal.ppat.1006230. eCollection 2017 Feb.

DOI:10.1371/journal.ppat.1006230
PMID:28225830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5338860/
Abstract

The fate of HIV-infected cells after reversal of proviral latency is not well characterized. Simonetti, et al. recently showed that CD4+ T-cells containing intact proviruses can clonally expand in vivo and produce low-level infectious viremia. We hypothesized that reversal of HIV latency by activation of CD4+ T-cells can lead to the expansion of a subset of virus-producing cells rather than their elimination. We established an ex vivo cell culture system involving stimulation of CD4+ T-cells from donors on suppressive antiretroviral therapy (ART) with PMA/ionomycin (day 1-7), followed by rest (day 7-21), and then repeat stimulation (day 21-28), always in the presence of high concentrations of raltegravir and efavirenz to effectively block new cycles of viral replication. HIV DNA and virion RNA in the supernatant were quantified by qPCR. Single genome sequencing (SGS) of p6-PR-RT was performed to genetically characterize proviruses and virion-associated genomic RNA. The replication-competence of the virions produced was determined by the viral outgrowth assay (VOA) and SGS of co-culture supernatants from multiple time points. Experiments were performed with purified CD4+ T-cells from five consecutively recruited donors who had been on suppressive ART for > 2 years. In all experiments, HIV RNA levels in supernatant increased following initial stimulation, decreased or remained stable during the rest period, and increased again with repeat stimulation. HIV DNA levels did not show a consistent pattern of change. SGS of proviruses revealed diverse outcomes of infected cell populations, ranging from their apparent elimination to persistence and expansion. Importantly, a subset of infected cells expanded and produced infectious virus continuously after stimulation. These findings underscore the complexity of eliminating reservoirs of HIV-infected cells and highlight the need for new strategies to kill HIV-infected cells before they can proliferate.

摘要

原病毒潜伏逆转后,HIV感染细胞的命运尚未得到充分表征。Simonetti等人最近表明,含有完整原病毒的CD4+ T细胞可在体内进行克隆扩增并产生低水平感染性病毒血症。我们假设,通过激活CD4+ T细胞逆转HIV潜伏可导致一部分病毒产生细胞的扩增,而非其清除。我们建立了一种体外细胞培养系统,包括用佛波酯/离子霉素刺激接受抑制性抗逆转录病毒疗法(ART)的供体的CD4+ T细胞(第1 - 7天),随后休息(第7 - 21天),然后重复刺激(第21 - 28天),始终在高浓度raltegravir和依非韦伦存在的情况下进行,以有效阻断病毒复制的新周期。通过qPCR对上清液中的HIV DNA和病毒体RNA进行定量。对p6 - PR - RT进行单基因组测序(SGS),以对原病毒和病毒体相关基因组RNA进行基因表征。通过病毒生长测定(VOA)和多个时间点共培养上清液的SGS确定产生的病毒体的复制能力。对连续招募的5名接受抑制性ART超过2年的供体的纯化CD4+ T细胞进行了实验。在所有实验中,上清液中的HIV RNA水平在初次刺激后升高,在休息期降低或保持稳定,并在重复刺激时再次升高。HIV DNA水平未显示出一致的变化模式。原病毒的SGS揭示了受感染细胞群体的不同结果,从明显清除到持续存在和扩增。重要 的是,一部分受感染细胞在刺激后持续扩增并产生感染性病毒。这些发现强调了消除HIV感染细胞储存库的复杂性,并突出了在HIV感染细胞增殖之前杀死它们的新策略的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/ddbf82a615b2/ppat.1006230.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/b62a1cd4fc2d/ppat.1006230.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/81662c515157/ppat.1006230.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/8502d2baa201/ppat.1006230.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/d237b32d1001/ppat.1006230.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/6d3df30b5932/ppat.1006230.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/ddbf82a615b2/ppat.1006230.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/b62a1cd4fc2d/ppat.1006230.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/81662c515157/ppat.1006230.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/8502d2baa201/ppat.1006230.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/d237b32d1001/ppat.1006230.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/6d3df30b5932/ppat.1006230.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa2/5338860/ddbf82a615b2/ppat.1006230.g006.jpg

相似文献

1
Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells.对接受抑制性抗逆转录病毒治疗的供体的CD4 + T细胞进行体外激活,可导致一部分受感染细胞持续产生具有传染性的HIV-1。
PLoS Pathog. 2017 Feb 22;13(2):e1006230. doi: 10.1371/journal.ppat.1006230. eCollection 2017 Feb.
2
Modeling HIV-1 Latency Using Primary CD4 T Cells from Virally Suppressed HIV-1-Infected Individuals on Antiretroviral Therapy.利用抗逆转录病毒治疗中病毒抑制的 HIV-1 感染者的原代 CD4 T 细胞建立 HIV-1 潜伏期模型。
J Virol. 2019 May 15;93(11). doi: 10.1128/JVI.02248-18. Print 2019 Jun 1.
3
Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy.定量分析接受抑制性抗逆转录病毒疗法患者的静止 CD4+T 细胞中的 HIV-1 潜伏期逆转。
Proc Natl Acad Sci U S A. 2014 May 13;111(19):7078-83. doi: 10.1073/pnas.1402873111. Epub 2014 Mar 31.
4
HIV-1 Virion Production from Single Inducible Proviruses following T-Cell Activation Ex Vivo.体外T细胞激活后单个可诱导原病毒产生HIV-1病毒颗粒
J Virol. 2015 Nov 11;90(3):1673-6. doi: 10.1128/JVI.02520-15. Print 2016 Feb 1.
5
Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.HIV-1在初始和中枢记忆CD4+T细胞中潜伏状态的建立与逆转的体外研究
J Virol. 2016 Aug 26;90(18):8059-73. doi: 10.1128/JVI.00553-16. Print 2016 Sep 15.
6
A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.一种新型Toll样受体9激动剂MGN1703增强HIV-1转录以及自然杀伤细胞介导的对HIV-1感染的自体CD4+ T细胞的抑制作用。
J Virol. 2016 Apr 14;90(9):4441-4453. doi: 10.1128/JVI.00222-16. Print 2016 May.
7
Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation.在病毒重新激活后刺激RIG-I通路以杀死潜伏性HIV储存库中的细胞。
Nat Med. 2016 Jul;22(7):807-11. doi: 10.1038/nm.4124. Epub 2016 Jun 13.
8
Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.超灵敏HIV-1 p24检测法可检测单个感染细胞以及潜伏逆转剂诱导的病毒储存库差异。
J Virol. 2017 Feb 28;91(6). doi: 10.1128/JVI.02296-16. Print 2017 Mar 15.
9
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.HIV-1储存库:在抗病毒免疫反应和抗逆转录病毒疗法存在的情况下病毒持续存在的机制
Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665.
10
Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.抗逆转录病毒治疗(ART)期间,残余病毒血症与驱动CD4(+) T细胞新发感染的病毒变体之间缺乏一致性。
Retrovirology. 2016 Aug 2;13(1):51. doi: 10.1186/s12977-016-0282-9.

引用本文的文献

1
Latency Reversing Agents and the Road to an HIV Cure.潜伏期逆转剂与治愈艾滋病的道路。
Pathogens. 2025 Feb 27;14(3):232. doi: 10.3390/pathogens14030232.
2
Single-Cell Transcriptomics of /HIV Co-Infection.单细胞转录组学分析 /HIV 共感染。
Cells. 2023 Sep 17;12(18):2295. doi: 10.3390/cells12182295.
3
Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients.治疗患者中复制型 HIV 储存库的基因和表型多样性。

本文引用的文献

1
Defective proviruses rapidly accumulate during acute HIV-1 infection.在急性HIV-1感染期间,缺陷型前病毒会迅速积累。
Nat Med. 2016 Sep;22(9):1043-9. doi: 10.1038/nm.4156. Epub 2016 Aug 8.
2
Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.克隆扩增的CD4+ T细胞可在体内产生具有传染性的HIV-1。
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1883-8. doi: 10.1073/pnas.1522675113. Epub 2016 Feb 8.
3
Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA.用于测量总细胞相关HIV-1 DNA和RNA的新型检测方法。
Microbiol Spectr. 2022 Aug 31;10(4):e0078422. doi: 10.1128/spectrum.00784-22. Epub 2022 Jun 30.
4
Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapy.脂质体植物血凝素:作为一种新型的泛癌免疫疗法,体内 T 细胞激活剂。
J Cell Mol Med. 2022 Feb;26(3):940-944. doi: 10.1111/jcmm.16885. Epub 2022 Jan 11.
5
New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir.利用多重置换扩增进行多参数 HIV-1 遗传学的新方法:确定 HIV-1 储存库的“是什么”、“怎么做”和“在哪里”。
Viruses. 2021 Dec 10;13(12):2475. doi: 10.3390/v13122475.
6
Chemistry and Bioinformatics Considerations in Using Next-Generation Sequencing Technologies to Inferring HIV Proviral DNA Genome-Intactness.使用下一代测序技术推断 HIV 前病毒 DNA 基因组完整性的化学和生物信息学考虑因素。
Viruses. 2021 Sep 19;13(9):1874. doi: 10.3390/v13091874.
7
Biogenesis of P-TEFb in CD4+ T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways.CD4+T 细胞中 P-TEFb 的生物发生逆转 HIV 潜伏期是由蛋白激酶 C(PKC)非依赖性信号通路介导的。
PLoS Pathog. 2021 Sep 16;17(9):e1009581. doi: 10.1371/journal.ppat.1009581. eCollection 2021 Sep.
8
The Correlation Between Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with Hepatic Echinococcosis.血小板与淋巴细胞比值及中性粒细胞与淋巴细胞比值与肝包虫病的相关性
J Inflamm Res. 2021 Jun 3;14:2403-2409. doi: 10.2147/JIR.S304307. eCollection 2021.
9
Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy.靶向 HIV-1 各亚型遗传变异的 gRNA 的计算设计用于 CRISPR 介导的抗病毒治疗。
Front Cell Infect Microbiol. 2021 Mar 9;11:593077. doi: 10.3389/fcimb.2021.593077. eCollection 2021.
10
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus.抗逆转录病毒治疗无法抑制的 HIV-1 病毒血症可能来源于产生感染性病毒的大 T 细胞克隆。
J Clin Invest. 2020 Nov 2;130(11):5847-5857. doi: 10.1172/JCI138099.
J Clin Microbiol. 2016 Apr;54(4):902-11. doi: 10.1128/JCM.02904-15. Epub 2016 Jan 13.
4
HIV-1 Virion Production from Single Inducible Proviruses following T-Cell Activation Ex Vivo.体外T细胞激活后单个可诱导原病毒产生HIV-1病毒颗粒
J Virol. 2015 Nov 11;90(3):1673-6. doi: 10.1128/JVI.02520-15. Print 2016 Feb 1.
5
A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.一种用于测量 HIV 感染者中诱导性病毒储存库大小的新方法。
EBioMedicine. 2015 Jun 27;2(8):874-83. doi: 10.1016/j.ebiom.2015.06.019. eCollection 2015 Aug.
6
Reversal of T-cell exhaustion as a strategy to improve immune control of HIV-1.逆转T细胞耗竭作为改善HIV-1免疫控制的一种策略。
AIDS. 2015 Sep 24;29(15):1911-5. doi: 10.1097/QAD.0000000000000788.
7
Molecular and cellular insights into T cell exhaustion.对T细胞耗竭的分子和细胞层面的见解。
Nat Rev Immunol. 2015 Aug;15(8):486-99. doi: 10.1038/nri3862.
8
Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis.自然杀伤细胞的异质性:细胞功能障碍及其在HIV-1免疫发病机制中的意义
Cell Mol Life Sci. 2015 Aug;72(16):3037-49. doi: 10.1007/s00018-015-1911-5. Epub 2015 May 5.
9
Towards an HIV-1 cure: measuring the latent reservoir.迈向治愈HIV-1:测量潜伏病毒库。
Trends Microbiol. 2015 Apr;23(4):192-203. doi: 10.1016/j.tim.2015.01.013. Epub 2015 Mar 5.
10
HIV-1 integration landscape during latent and active infection.潜伏感染和活跃感染期间的HIV-1整合图谱。
Cell. 2015 Jan 29;160(3):420-32. doi: 10.1016/j.cell.2015.01.020.